These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2778187)

  • 1. Decreased leukocyte ferrochelatase activity in erythropoietic protoporphyria.
    Kondo M; Ohe M; Mizuguchi M
    J Dermatol; 1989 Apr; 16(2):116-21. PubMed ID: 2778187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished erythroid ferrochelatase activity in protoporphyria.
    Bottomley SS; Tanaka M; Everett MA
    J Lab Clin Med; 1975 Jul; 86(1):126-31. PubMed ID: 1151134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria.
    Nunn AV; Norris P; Hawk JL; Cox TM
    Anal Biochem; 1988 Oct; 174(1):146-50. PubMed ID: 3218729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect.
    Sassa S; Schwartz S; Ruth G
    J Exp Med; 1981 May; 153(5):1094-101. PubMed ID: 6788885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in porphyria: functional evidence for a partial deficiency of ferrochelatase activity in mitogen-stimulated lymphocytes from patients with erythropoietic protoporphyria.
    Sassa S; Zalar GL; Poh-Fitzpatrick MB; Anderson KE; Kappas A
    J Clin Invest; 1982 Apr; 69(4):809-15. PubMed ID: 6804493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria.
    Buzaleh AM; Morán-Jiménez MJ; Garcia-Bravo M; Sampedro A; Batlle AM; Enriquez de Salamanca R; Fontanellas A
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):38-44. PubMed ID: 19268000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protoporphyrin accumulation by mitogen stimulated lymphocytes and protoporphyrinogen oxidase activity in patients with porphyria variegata and erythropoietic protoporphyria: evidence for deficiency of protoporphyrinogen oxidase and ferrochelatase in both diseases.
    Siepker LJ; Kramer S
    Br J Haematol; 1985 May; 60(1):65-74. PubMed ID: 3924091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked dominant protoporphyria: The first reported Japanese case.
    Ninomiya Y; Kokunai Y; Tanizaki H; Akasaka E; Nakano H; Moriwaki S
    J Dermatol; 2016 Apr; 43(4):414-8. PubMed ID: 26387792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ethanol ingestion and haem biosynthesis in healthy subjects.
    McColl KE; Thompson GG; Moore MR; Goldberg A
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):107-12. PubMed ID: 6780356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different characteristics of ferrochelatase in cultured fibroblasts of erythropoietic protoporphyria patients and normal controls.
    Blom C; Klasen EC; Van Steveninck J
    Biochim Biophys Acta; 1990 Jul; 1039(3):339-42. PubMed ID: 2378891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biosynthesis of haem in congenital (erythropoietic) porphyria.
    Moore MR; Thompson GG; Goldberg A; Ippen H; Seubert A; Seubert S
    Int J Biochem; 1978; 9(12):933-8. PubMed ID: 744299
    [No Abstract]   [Full Text] [Related]  

  • 12. Protoporphyrinogen oxidase and ferrochelatase in porphyria variegata.
    Viljoen DJ; Cummins R; Alexopoulos J; Kramer S
    Eur J Clin Invest; 1983 Aug; 13(4):283-7. PubMed ID: 6413214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme biosynthesis in sideroblastic anemia.
    Pasanen AV; Salmi M; Vuopio P; Tenhunen R
    Int J Biochem; 1980; 12(5-6):969-74. PubMed ID: 7450158
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme abnormalities in the porphyrias.
    Brodie MJ; Moore MR; Goldberg A
    Lancet; 1977 Oct; 2(8040):699-701. PubMed ID: 71507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
    Balwani M; Doheny D; Bishop DF; Nazarenko I; Yasuda M; Dailey HA; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Liu L; Desnick RJ;
    Mol Med; 2013 Apr; 19(1):26-35. PubMed ID: 23364466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrochelatase activities in patients with erythropoietic protoporphyria and their families.
    Goerz G; Bunselmeyer S; Bolsen K; Schürer NY
    Br J Dermatol; 1996 May; 134(5):880-5. PubMed ID: 8736329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of acute intermittent porphyria with laevulose.
    Brodie MJ; Moore MR; Thompson GG; Goldberg A
    Clin Sci Mol Med; 1977 Oct; 53(4):365-71. PubMed ID: 913061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families.
    Norris PG; Nunn AV; Hawk JL; Cox TM
    J Invest Dermatol; 1990 Sep; 95(3):260-3. PubMed ID: 2384686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haem biosynthesis in cutaneous hepatic porphyria: comparison with alcoholism and liver disease.
    Brodie MJ; Thompson GG; Moore MR; McColl KE; Goldberg A; Hardie RA; Hunter JA
    Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):122-8. PubMed ID: 463487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decreased heme synthetase activity in erythroblasts in two patients with erythropoietic protoporphyria (author's transl)].
    Kaneko K; Sanada M; Imaizumi S; Koike T; Miyashita M; Shibata A
    Rinsho Ketsueki; 1981 Dec; 22(12):2023-33. PubMed ID: 7345186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.